Viral exposures and MS outcome in a prospective cohort of children with acquired demyelination

Multiple Sclerosis

Volumn 22, Issue 3, 2016, Pages 385-388

  Makhani, Naila ^a   Banwell, Brenda ^b   Tellier, Raymond ^c   Yea, Carmen ^e   McGovern, Suzanne ^e   O'Mahony, Julia ^d   Ahorro, Jean M ^f   Arnold, Douglas ^g   Sadovnick, A Dessa ^h   Marrie, Ruth A ⁱ   Bar Or, Amit ^g  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e HOSPITAL FOR SICK CHILDREN   (Canada)

^f Calamba Doctors' Hospital   (Philippines)

^g MCGILL UNIVERSITY   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ UNIVERSITY OF MANITOBA   (Canada)

Author keywords

cytomegalovirus; Epstein Barr virus; Multiple sclerosis; pediatric; risk factors

Indexed keywords

25 HYDROXYVITAMIN D; HLA DRB1 ANTIGEN; VIRUS ANTIGEN; HLA ANTIGEN; IMMUNOGLOBULIN G; VIRUS ANTIBODY;

ADOLESCENT; ALLELE; ANTIBODY TITER; ARTICLE; COHORT ANALYSIS; CYTOMEGALOVIRUS INFECTION; DEMYELINATION; EPSTEIN BARR VIRUS; EPSTEIN BARR VIRUS INFECTION; FOLLOW UP; HERPES SIMPLEX; HERPES SIMPLEX VIRUS; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SERODIAGNOSIS; SEROPREVALENCE; ACQUIRED DEMYELINATING SYNDROME; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; MALE; POLYMERASE CHAIN REACTION; RISK; SEROLOGY; VARICELLA ZOSTER VIRUS; VIRUS INFECTION; BLOOD; CHICKENPOX; COMPLICATION; CYTOMEGALOVIRUS INFECTIONS; DEMYELINATING DISEASE; EPSTEIN-BARR VIRUS INFECTIONS; PROPORTIONAL HAZARDS MODEL; VIROLOGY;

ANTIBODIES, VIRAL; CHICKENPOX; CHILD; COHORT STUDIES; CYTOMEGALOVIRUS INFECTIONS; DEMYELINATING DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPSTEIN-BARR VIRUS INFECTIONS; FEMALE; HERPES SIMPLEX; HUMANS; IMMUNOGLOBULIN G; MALE; MULTIPLE SCLEROSIS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SEROEPIDEMIOLOGIC STUDIES;

EID: 84986593190     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458515595876     Document Type: Article

References (9)

1. Banwell B, Bar-Or A, Arnold DL, et al. Clinical, environmental, and genetic determinants of multiple sclerosis in children with acute demyelination: a prospective national cohort study. Lancet Neurol 2011; 10: 436-445.
2. Sundqvist E, Bergstrom T, Daialhosein H, et al. Cytomegalovirus seropositivity is negatively associated with multiple sclerosis. Mult Scler 2014; 20: 165-173.
3. Waubant E, Mowry EM, Krupp L, et al. Common viruses associated with lower pediatric multiple sclerosis risk. Neurology 2011; 76: 1989-1995.
4. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006; 66: 1485-1489.
5. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 2005; 58: 840-846.
6. Disanto G, Magalhaes S, Handel AE, et al. HLA-DRB1 confers increased risk of pediatric-onset MS in children with acquired demyelination. Neurology 2011; 76: 781-786.
7. Andersson T, Alfredsson L, Kallberg H, et al. Calculating measures of biological interaction. Eur J Epidemiol 2005; 20: 575-579.
8. Halenius A, Hengel H., Human cytomegalovirus and autoimmune disease. BioMed Res Int 2014; 2014: 472978.
9. Lunemann JD, Jelcic I, Roberts S, et al. EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2. J Exp Med 2008; 205: 1763-1773.